Boston Partners’s Adient ADNT Stock Holding History

Boston Partners’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-17,522	Closed	-$28.4K	–	769
2023 Q4	$28.4K	Sell	17,522 -11,130	-39%	-$382K	﹤0.01%	703
2023 Q3	$44.4K	Buy	+28,652	New	+$1.14M	﹤0.01%	719

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners's ADNT Position: Q1 2024 in Review

Boston Partners sold out of Adient (ADNT) in Q1 2024, closing a stake of 17,522 shares — an estimated $28.4K sold.

Boston Partners first reported a position in ADNT in Q3 2023 and held it in 2 quarters. The position peaked at $44.4K in Q3 2023. 312 funds tracked by Wall St. Rank hold ADNT as of Q1 2024.

Boston Partners reported no remaining Adient position as of Q1 2024 after selling out during the quarter.
Boston Partners sold 17,522 Adient shares in Q1 2024, an estimated $28.4K.
Boston Partners first reported a position in Adient in Q3 2023 and held it in 2 quarters.
Boston Partners's Adient position peaked at $44.4K in Q3 2023.
312 funds tracked by Wall St. Rank held Adient as of Q1 2024.

Based on Boston Partners's 13F filing for Q1 2024, filed 13 May 2024.